Cargando…
Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100237/ https://www.ncbi.nlm.nih.gov/pubmed/36398869 http://dx.doi.org/10.1111/pin.13288 |
_version_ | 1785025232674750464 |
---|---|
author | Yorozu, Keigo Kurasawa, Mitsue Iino, Yuki Nakamura, Yuka Hashizume, Kaoru Harada, Naoki Ochiai, Atsushi |
author_facet | Yorozu, Keigo Kurasawa, Mitsue Iino, Yuki Nakamura, Yuka Hashizume, Kaoru Harada, Naoki Ochiai, Atsushi |
author_sort | Yorozu, Keigo |
collection | PubMed |
description | Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting the importance of improving HER2 detection accuracy in clinical practice. We prepared tissue microarray (TMA) slides for use as control slides for the standardization of gastric HER2 testing. Four human gastric cancer cell lines with HER2 scores of 3+, 2+, 1+, and 0 were xenografted in NOG mice. The TMA slides were constructed using samples from three different areas in these tumors. Staining properties were determined using six clinical kits for HER2. In TMA, HER2‐positive tumors with HER2 scores of 3+ and 2+ showed good staining with all diagnostic kits, and the tissue images were similar to those of clinical samples. Xenograft tumor slides could potentially be used as external controls to standardize staining conditions for a variety of kits and may improve the accuracy of HER2 detection in clinical practice. |
format | Online Article Text |
id | pubmed-10100237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101002372023-04-14 Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection Yorozu, Keigo Kurasawa, Mitsue Iino, Yuki Nakamura, Yuka Hashizume, Kaoru Harada, Naoki Ochiai, Atsushi Pathol Int Short Communication Gene amplification and protein overexpression of human epidermal growth factor receptor type 2 (HER2) are specific targets for HER2‐targeting drugs in breast, gastric, salivary gland, and colorectal cancers. The histopathological determination of HER2 status is crucial for treatment, highlighting the importance of improving HER2 detection accuracy in clinical practice. We prepared tissue microarray (TMA) slides for use as control slides for the standardization of gastric HER2 testing. Four human gastric cancer cell lines with HER2 scores of 3+, 2+, 1+, and 0 were xenografted in NOG mice. The TMA slides were constructed using samples from three different areas in these tumors. Staining properties were determined using six clinical kits for HER2. In TMA, HER2‐positive tumors with HER2 scores of 3+ and 2+ showed good staining with all diagnostic kits, and the tissue images were similar to those of clinical samples. Xenograft tumor slides could potentially be used as external controls to standardize staining conditions for a variety of kits and may improve the accuracy of HER2 detection in clinical practice. John Wiley and Sons Inc. 2022-11-18 2023-01 /pmc/articles/PMC10100237/ /pubmed/36398869 http://dx.doi.org/10.1111/pin.13288 Text en © 2022 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Short Communication Yorozu, Keigo Kurasawa, Mitsue Iino, Yuki Nakamura, Yuka Hashizume, Kaoru Harada, Naoki Ochiai, Atsushi Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title | Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title_full | Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title_fullStr | Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title_full_unstemmed | Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title_short | Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection |
title_sort | methods for preparing tissue microarray slides using xenografts with different levels of her2 expression to standardize her2 detection |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100237/ https://www.ncbi.nlm.nih.gov/pubmed/36398869 http://dx.doi.org/10.1111/pin.13288 |
work_keys_str_mv | AT yorozukeigo methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT kurasawamitsue methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT iinoyuki methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT nakamurayuka methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT hashizumekaoru methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT haradanaoki methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection AT ochiaiatsushi methodsforpreparingtissuemicroarrayslidesusingxenograftswithdifferentlevelsofher2expressiontostandardizeher2detection |